drugset

drugset / Trial / NCT00035854

New Antibiotic to Treat Pediatric Patients With Infections Due to a Specific Bacteria (Vancomycin-Resistant Enterococcus)

NCT00035854 ↗

Phase 3 Completed 13 enrolled Pfizer

RandomizedSingle-groupOpen-labelTreatment

Summary

This study will treat pediatric patients who have infections that are due to a specific bacteria (Vancomycin-Resistant Enterococcus)

Timeline

Start: 2002-02
Primary completion: —
Completion: 2004-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Linezolid	Other / unclassified	—	Intravenous

Indications